Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis.

Kim A HoffmanRobin BakerLaura C FanucchiPaula J LumLynn E KunkelJavier Ponce TerashimaDennis McCartyPetra JacobsP Todd Korthuis

Published in: Addiction science & clinical practice (2021)

The results highlight opportunities to improve initiation of XR-NTX in high-need groups. Addressing expectations regarding induction may enhance XR-NTX initiation rates. Trial Registration ClinicalTrials.gov: NCT03275350. Registered September 7, 2017. https://clinicaltrials.gov/ct2/show/NCT03275350?term=extended+release+naltrexone&cond=Opioid+Use .

Keyphrases

alcohol use disorder
computed tomography
study protocol
clinical trial
preterm infants
image quality
phase iii
contrast enhanced
dual energy
magnetic resonance imaging
randomized controlled trial
gestational age
positron emission tomography
magnetic resonance
open label